We are live on ! Find out more
AB

Amalgamated Bank Portfolio holdings

AUM $14.5B
1-Year Est. Return 44.3%
This Fund
S&P 500
This Quarter Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
Cap. Flow
+$6.37M
Cap. Flow %
0.05%
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24

Top Buys

Rank Stock Value
1
ACN icon
Accenture
ACN
+$60.7M
2
MDT icon
Medtronic
MDT
+$35.8M
3
AAPL icon
Apple
AAPL
+$30.8M
4
MSFT icon
Microsoft
MSFT
+$28.5M
5
LIN icon
Linde
LIN
+$24.3M

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Financials 13.28%
3 Healthcare 13.15%
4 Consumer Discretionary 12.03%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGNE icon
2976
Neurogene
NGNE
$672M
$9K ﹤0.01%
+231
New +$13.5K
NPCE icon
2977
Neuropace
NPCE
$465M
$9K ﹤0.01%
+1,156
New +$9.97K
SLDB icon
2978
Solid Biosciences
SLDB
$792M
$9K ﹤0.01%
+479
New +$8.45K
SPRY icon
2979
ARS Pharmaceuticals
SPRY
$579M
$9K ﹤0.01%
+2,469
New +$10.7K
CLYM
2980
Climb Bio
CLYM
$693M
$9K ﹤0.01%
+1,039
New +$9.69K
TAST
2981
DELISTED
Carrols Restaurant Group, Inc.
TAST
$9K ﹤0.01%
+4,025
New +$10.4K
SRT
2982
DELISTED
Startek Inc.
SRT
$9K ﹤0.01%
+2,027
New +$9.57K
HMTV
2983
DELISTED
Hemisphere Media Group, Inc.
HMTV
$9K ﹤0.01%
+1,949
New +$11.7K
ACIC icon
2984
American Coastal Insurance
ACIC
$536M
$8K ﹤0.01%
+2,448
New +$9.26K
AXDX
2985
DELISTED
Accelerate Diagnostics
AXDX
$8K ﹤0.01%
+537
New +$15.3K
BDTX icon
2986
Black Diamond Therapeutics
BDTX
$95.1M
$8K ﹤0.01%
+2,742
New +$10K
BOLT icon
2987
Bolt Biotherapeutics
BOLT
$7.4M
$8K ﹤0.01%
+138
New +$9.29K
BYSI icon
2988
BeyondSpring
BYSI
$47.3M
$8K ﹤0.01%
+3,647
New +$10.6K
CVRX icon
2989
CVRx
CVRX
$131M
$8K ﹤0.01%
+1,259
New +$10.2K
ELTX icon
2990
Elicio Therapeutics
ELTX
$75.9M
$8K ﹤0.01%
+373
New +$8.42K
IMRX icon
2991
Immuneering
IMRX
$262M
$8K ﹤0.01%
+1,219
New +$11.7K
KRRO icon
2992
Korro Bio
KRRO
$145M
$8K ﹤0.01%
+77
New +$14.7K
LVO icon
2993
LiveOne
LVO
$59.8M
$8K ﹤0.01%
1,006
-29
-3% -$253
RPID icon
2994
Rapid Micro Biosystems
RPID
$102M
$8K ﹤0.01%
+1,241
New +$9.14K
VHI icon
2995
Valhi
VHI
$389M
$8K ﹤0.01%
+290
New +$7.88K
XLO icon
2996
Xilio Therapeutics
XLO
$59.8M
$8K ﹤0.01%
+77
New +$12.2K
CSSE
2997
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$8K ﹤0.01%
+966
New +$10.1K
ALGS icon
2998
Aligos Therapeutics
ALGS
$26.3M
$7K ﹤0.01%
+138
New +$11.1K
AVTX icon
2999
Avalo Therapeutics
AVTX
$1.01B
$7K ﹤0.01%
3
-1
-25% -$2.51K
FOA icon
3000
Finance of America Companies
FOA
$222M
$7K ﹤0.01%
+223
New +$7.77K

Similar funds

Amalgamated Bank's Q1 2022 Portfolio in Review

As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.

  • Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
  • Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
  • Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
  • Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
  • Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
  • Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
  • Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.

Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.